Semaglutide is the active ingredient in Ozempic and Wegovy, with Ozempic primarily for diabetes management and Wegovy for weight loss
Detoxifies & fights oxidative stress
GLP-1 therapy may be appropriate for individuals who: Have a body mass index (BMI) of 27 or higher with weight-related health conditions (e.g., diabetes, hypertension)
Consult a GP if you have a medical condition or take medication
Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said Friday
If youve heard about the buzz around Semaglutide a GLP1 receptor agonist thats been shown to cut appetite and drive meaningful weight loss, youre probably wondering whether you can get it from Hers Health an online telehealth platform that now prescribes weightloss medication
